+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Stroke Prevention in Atrial Fibrillation

  • ID: 4455131
  • Book
  • June 2018
  • Region: Global
  • 202 Pages
  • Elsevier Health Science
1 of 3

Get a quick, expert overview of stroke risks among patients with treated and untreated atrial fibrillation, in addition to best practices for management and treatment of patients with atrial fibrillation to minimize stroke risks. This concise, clinically-focused resource by Dr. Greg Flaker consolidates today's available information on this timely topic into one convenient resource, making it an ideal, easy-to-digest reference for practicing and trainee cardiologists as well as general practitioners treating and monitoring these patients.

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Note: Product cover images may vary from those shown
2 of 3

1. Economic and Social Overview of Stroke Related to Atrial Fibrillation

2. Pharmacology of Anticoagulants- VKA and NOAC's

3. Anticoagulation Drug Trials for Stroke Prevention in Atrial Fibrillation

4. Risk Stratification

5. Subclinical Atrial Fibrillation

6. The New Anticoagulation Clinic

7. Management of Bleeding Associated with Anticoagulation

8. Periprocedural Management

9. Special Situations: Anticoagulation for Cardioversion

10. Special Situations: Anticoagulation for Ablation

11. Surgical and Implanted Devices for the Left Atrial Appendage

12. Anticoagulation of the Atrial Fibrillation Patient with Other Medical Conditions

13. Stroke and Atrial Fibrillation: The Neurologist's Perspective

14. Atrial Fibrillation and Chronic Kidney Disease

Note: Product cover images may vary from those shown
3 of 3


4 of 3
Flaker, Greg Professor of Medicine, Department of Cardiovascular Medicine, University of Missouri Health School of Medicine, Columbia, Missouri.
Note: Product cover images may vary from those shown